Immune Mechanisms Involved in Schistosoma mansoni-Cathepsin B Vaccine Induced Protection in Mice
A vaccine against schistosomiasis would contribute to a long-lasting decrease in disease spectrum and transmission. Our previous protection studies in mice using Schistosoma mansoni Cathepsin B (Sm-Cathepsin B) resulted in 59 and 60% worm burden reduction with CpG oligodeoxynucleotides and Montanide...
Main Authors: | Alessandra Ricciardi, Nicholas H. Zelt, Kittipos Visitsunthorn, John P. Dalton, Momar Ndao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01710/full |
Similar Items
-
Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
by: Dilhan J. Perera, et al.
Published: (2020-11-01) -
Promising Technologies in the Field of Helminth Vaccines
by: Dilhan J. Perera, et al.
Published: (2021-08-01) -
Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.
by: Adam S Hassan, et al.
Published: (2019-12-01) -
A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice
by: Elahi, S.M, et al.
Published: (2022) -
Vaccination with <i>Schistosoma mansoni</i> Cholinesterases Reduces the Parasite Burden and Egg Viability in a Mouse Model of Schistosomiasis
by: Bemnet A. Tedla, et al.
Published: (2020-04-01)